Literature DB >> 23462929

Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1).

Koji Aoyama1, Toshio Nakaki.   

Abstract

Extracellular glutamate should be maintained at low levels to conserve optimal neurotransmission and prevent glutamate neurotoxicity in the brain. Excitatory amino acid transporters (EAATs) play a pivotal role in removing extracellular glutamate in the central nervous system (CNS). Excitatory amino acid carrier 1 (EAAC1) is a high-affinity Na⁺-dependent neuronal EAAT that is ubiquitously expressed in the brain. However, most glutamate released in the synapses is cleared by glial EAATs, but not by EAAC1 in vivo. In the CNS, EAAC1 is widely distributed in somata and dendrites but not in synaptic terminals. The contribution of EAAC1 to the control of extracellular glutamate levels seems to be negligible in the brain. However, EAAC1 can transport not only extracellular glutamate but also cysteine into the neurons. Cysteine is an important substrate for glutathione (GSH) synthesis in the brain. GSH has a variety of neuroprotective functions, while its depletion induces neurodegeneration. Therefore, EAAC1 might exert a critical role for neuroprotection in neuronal GSH metabolism rather than glutamatergic neurotransmission, while EAAC1 dysfunction would cause neurodegeneration. Despite the potential importance of EAAC1 in the brain, previous studies have mainly focused on the glutamate neurotoxicity induced by glial EAAT dysfunction. In recent years, however, several studies have revealed regulatory mechanisms of EAAC1 functions in the brain. This review will summarize the latest information on the EAAC1-regulated neuroprotective functions in the CNS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462929     DOI: 10.1007/s00726-013-1481-5

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  21 in total

Review 1.  Lens glutathione homeostasis: Discrepancies and gaps in knowledge standing in the way of novel therapeutic approaches.

Authors:  Xingjun Fan; Vincent M Monnier; Jeremy Whitson
Journal:  Exp Eye Res       Date:  2016-06-29       Impact factor: 3.467

Review 2.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

3.  Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Authors:  Meredith C Lane; Joshua G Jackson; Elizabeth N Krizman; Jeffery D Rothstein; Brenda E Porter; Michael B Robinson
Journal:  Neurochem Int       Date:  2013-12-12       Impact factor: 3.921

Review 4.  Glutathione-Dependent Detoxification Processes in Astrocytes.

Authors:  Ralf Dringen; Maria Brandmann; Michaela C Hohnholt; Eva-Maria Blumrich
Journal:  Neurochem Res       Date:  2014-11-27       Impact factor: 3.996

5.  Neurorestorative targets of dietary long-chain omega-3 fatty acids in neurological injury.

Authors:  Johnny D Figueroa; Marino De Leon
Journal:  Mol Neurobiol       Date:  2014-04-17       Impact factor: 5.590

Review 6.  Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.

Authors:  Z Martinez-Lozada; A M Guillem; M B Robinson
Journal:  Adv Pharmacol       Date:  2016-03-24

7.  Cysteine transport through excitatory amino acid transporter 3 (EAAT3).

Authors:  Spencer D Watts; Delany Torres-Salazar; Christopher B Divito; Susan G Amara
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 8.  Glutathione in the Brain.

Authors:  Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

Review 9.  Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson's Disease.

Authors:  Xiang Li; Wenjun Wang; Jianghong Yan; Fancai Zeng
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 10.  Impaired glutathione synthesis in neurodegeneration.

Authors:  Koji Aoyama; Toshio Nakaki
Journal:  Int J Mol Sci       Date:  2013-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.